IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses
Authors:
- Karin PrinzKPKarin Prinz
- Alena EgyedAEAlena Egyed
- Jörg H. FritzJFJörg H. Fritz
- Barbara WittmannBWBarbara Wittmann
- Michael GinzlerMGMichael Ginzler
- Gabriele SwatoschGSGabriele Swatosch
- Wolfgang ZaunerWZWolfgang Zauner
- Constantia KastCKConstantia Kast
- Shizuo AkiraSAShizuo Akira
- Alexander von GabainAGAlexander von Gabain
- Michael BuschleMBMichael Buschle
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Toll-Like Receptor Signaling PathwaysScience, 2003
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Cross-presentation in viral immunity and self-toleranceNature Reviews Immunology, 2001
- Immunobiology of Dendritic CellsAnnual Review of Immunology, 2000
- Immunostimulatory DNA: Sequence‐dependent production of potentially harmful or useful cytokinesEuropean Journal of Immunology, 1997
- Bacterial DNA causes septic shockNature, 1997
- Adjuvants—a classification and review of their modes of actionVaccine, 1997
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.Journal of Experimental Medicine, 1992
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991